SLC4A7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.083500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.299600E-02
Normal-vs-Stage2
6.338300E-02
Normal-vs-Stage3
2.680300E-02
Normal-vs-Stage4
2.977000E-01
Stage1-vs-Stage2
5.567200E-01
Stage1-vs-Stage3
2.525800E-01
Stage1-vs-Stage4
3.066400E-01
Stage2-vs-Stage3
1.583030E-01
Stage2-vs-Stage4
2.469800E-01
Stage3-vs-Stage4
2.842200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.760500E-02
Normal-vs-AfricanAmerican
7.570200E-01
Normal-vs-Asian
5.580300E-02
Caucasian-vs-AfricanAmerican
2.936800E-01
Caucasian-vs-Asian
5.392800E-01
AfricanAmerican-vs-Asian
1.380960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.659900E-02
Normal-vs-Female
4.474100E-02
Male-vs-Female
6.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.318200E-01
Normal-vs-Age(41-60Yrs)
2.027400E-01
Normal-vs-Age(61-80Yrs)
1.600190E-02
Normal-vs-Age(81-100Yrs)
6.915300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.643200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.499600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.722200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.916400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.139500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.368150E-02
Normal-vs-Daily Drinker
1.259760E-01
Normal-vs-Weekly Drinker
1.252250E-02
Normal-vs-Occasional Drinker
5.001600E-02
Normal-vs-Social Drinker
1.845990E-01
Non Drinker-vs-Daily Drinker
2.564100E-02
Non Drinker-vs-Weekly Drinker
7.270400E-01
Non Drinker-vs-Occasional Drinker
9.519600E-01
Non Drinker-vs-Social Drinker
2.835600E-01
Daily Drinker-vs-Weekly Drinker
8.618000E-02
Daily Drinker-vs-Occasional Drinker
1.059580E-01
Daily Drinker-vs-Social Drinker
2.403700E-02
Weekly Drinker-vs-Occasional Drinker
8.209800E-01
Weekly Drinker-vs-Social Drinker
2.582000E-01
Occasional Drinker-vs-Social Drinker
3.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.037600E-01
Normal-vs-Grade 2
2.513400E-01
Normal-vs-Grade 3
1.997200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.568200E-01
Grade 1-vs-Grade 3
4.934400E-01
Grade 1-vs-Grade 4
4.037600E-01
Grade 2-vs-Grade 3
8.475200E-01
Grade 2-vs-Grade 4
2.513400E-01
Grade 3-vs-Grade 4
1.997200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.504300E-02
Normal-vs-NonDiabetic
2.154100E-02
Diabetic-vs-NonDiabetic
8.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.074100E-02
Normal-vs-NoPancreatitis
1.925930E-02
Pancreatitis-vs-NoPancreatitis
9.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.834200E-02
Normal-vs-N1
4.822400E-02
N0-vs-N1
2.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.141000E-03
Normal-vs-TP53-NonMutant
1.965780E-01
TP53-Mutant-vs-TP53-NonMutant
2.555700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
